In vitro diagnostic raw materials are undoubtedly one of the most important and critical factors in the development of high-performance in vitro diagnostic reagents. The quality and performance of in vitro diagnostic raw materials not only affect the performance, stability, credibility, and R&D process of diagnostic reagents of various technical platforms, but also affect whether diagnostic products can quickly pass process transformation verification and enter large-scale production. This is also the main reason why in vitro diagnostic companies attach so much importance to raw material quality, such as performance, batch stability, etc.

In addition, since the outbreak of COVID-19 in 2020, the demand for new coronavirus antibodies, antigens and nucleic acid detection reagents (after the large-scale application of vaccines, the latter two reagents are mainly used) has surged at home and abroad, and at the same time, it has led to a large demand for raw materials by in vitro diagnostic companies. The importance of the in vitro diagnostic raw material supply chain also directly plays a vital role in whether each in vitro diagnostic reagent company can deliver on time according to market demand.

At present, Jiachun continues to expand its R&D and production capabilities, continuously integrates its own resources, and has successively developed a large number of in vitro diagnostic raw material products that meet market demand, and fully guarantees the supply of product production capacity, providing solid support for our customers.